• Home>
  • Stocks>
  • Lincoln Pharmaceuticals Ltd Share Price
Lincoln Pharmaceuticals Ltd share price logo

Lincoln Pharmaceuticals Ltd Share Price (LINCOLN)

₹550.550.42%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Lincoln Pharmaceuticals Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹545
    ₹557.8
    downward going graph

    1.01%

    Downside

    1.32%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹499
    ₹979.5
    downward going graph

    9.36%

    Downside

    77.91%

    Upside

    downward going graph
Previous Close₹548.25
Open₹549.00
Volume28.21K
Upper Circuit₹657.90
Lower Circuit₹438.60
Day's Low545
Day's High557.8
52 Week Low499
52 Week High979.5
1 Month Return-1.23 %
3 Month Return-0.28 %
1 Year Return-23.84 %
3 Year Return+ 95.04 %
5 Year Return+ 122.82 %

Lincoln Pharmaceuticals Ltd Stock Fundamentals & Key Indicators

Check Lincoln Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹1,098.13 Cr

Return on Equity (ROE)

17.04

PE Ratio (TTM)

12.71

Return on capital employed (ROCE)

22.35

Industry PE ratio

43.37

Beta (LTM)

1.12

P/B Ratio

1.98

Dividend Yield

0.31

PEG Ratio

-2.2

Quarterly Earnings Growth YOY

16.94

EPS (TTM)

46.58

Sector

Pharmaceuticals

Book Value

295.98

Technical Analysis

Lincoln Pharmaceuticals Ltd Stock's Interest Amongst Investors

135%

Period Aug 23, 2025 to Jul 24, 2025. Change in 30 Days vs previous period

Search interest for Lincoln Pharmaceuticals Ltd Stock has increased by 135% in the last 30 days, reflecting an upward trend in search activity.

Lincoln Pharmaceuticals Ltd Stock Valuation

Track how Lincoln Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.

Lincoln Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.58x)

March 23, 2020

Today (12.71x)

August 21, 2025

Industry (43.37x)

August 21, 2025

Highest (19.77x)

December 9, 2024

LowHigh

Today’s Price to Earnings Ratio: 12.71x

Lincoln Pharmaceuticals Ltd Financial Results

Get the annual and quarterly financial summary of Lincoln Pharmaceuticals Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

147 (0%)161 (9%)147 (9%)168 (15%)154 (8%)
Net Income

(in ₹ Cr)

24 (0%)26 (11%)21 (21%)12 (44%)28 (139%)
Net Profit Margin16.07% (0%)16.33% (2%)14.17% (13%)6.89% (51%)17.97% (161%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

452 (0%)535 (18%)588 (10%)701 (19%)
Total Liabilities

(in ₹ Cr)

86 (0%)102 (19%)86 (16%)108 (27%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

71 (0%)69 (2%)76 (10%)39 (49%)63 (61%)

Lincoln Pharmaceuticals Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Lincoln Pharmaceuticals Ltd.

  • Lincoln Pharmaceuticals Ltd Earnings Results

    Lincoln Pharmaceuticals Ltd’s net profit jumped 16.94% since last year same period to ₹27.68Cr in the Q1 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 139.03% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Lincoln Pharmaceuticals Ltd Dividends May,2024

    In the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 per share on 16 May 2024 - translating a dividend yield of 0.60%.

    Read More about Dividends

Indices Featuring Lincoln Pharmaceuticals Ltd Stock

Check stock indices that include Lincoln Pharmaceuticals Ltd.

BSE Healthcare

₹44,807.68

0.09 (40.48%)

BSE Small-Cap

₹53,002.32

-0.35 (-183.71%)

Lincoln Pharmaceuticals Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Lincoln Pharmaceuticals Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
49.78%
0.00
Foreign Institutions
5.14%
2.86
Mutual Funds
0%
5.88
Retail Investors
45.07%
-0.33
Others
0.01%
106.82

Lincoln Pharmaceuticals Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Lincoln Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA1,098.1324.56%0.5093580
NA144.7017.83%0.847339
NA509.1222.09%0.00NANA
NA732.0831.15%0.514211,280
NA6.03-7.89%0.00-6NA

Lincoln Pharmaceuticals Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Lincoln Pharmaceuticals Ltd.

  • Lincoln Pharma Q1 Results Show Strong Growth - 07 Aug, 2025

    Lincoln Pharmaceuticals reported a 17% increase in net profit to ₹28 crore for Q1 FY26, with total income rising 7.3%. Shares surged 8.5% following the announcement. The company aims for ₹1,000 crore revenue in three years, focusing on high-value products and new markets.

Insights on Lincoln Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 11.58 Cr → 27.68 Cr (in ₹), with an average increase of 58.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.00% to 5.14% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 155.52 Cr → 169.34 Cr (in ₹), with an average increase of 4.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 43.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.78% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 46.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, LINCOLN stock has moved down by -2.4%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 45.22% to 45.07% in Jun 2025 quarter

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals, established in January 1979 as a partnership firm, was converted into a public limited company in January 1995. Primarily set up to manufacture pharmaceutical formulations such as tablets, capsules, syrups and ointments, they also obtained products from other licensed manufacturers to meet the demands of small volume parenterals. In order to increase production capacity, the company set up a modern formulation plant in Khatraj, Gujarat, and established an in-house laboratory for quality control and R&D. To fund its projects, the firm launched a public issue in February 1996, and in the year 2000, they were granted ISO 9002 and WHO certification. As a result, Lincoln Pharmaceuticals is now a leading manufacturer of quality pharmaceuticals that is continuously working to improve its operations.

Revenue: ₹154.07Cr as on June 2025 (Q1 FY26)
Net Profit: ₹27.68Cr as on June 2025 (Q1 FY26)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
OrganisationLincoln Pharmaceuticals Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOKishorbhai M Shah
E-voting on sharesClick here to vote

Mutual Funds that own Lincoln Pharmaceuticals Ltd Stock

Check out the Mutual Funds with significant holdings in Lincoln Pharmaceuticals Ltd.

FAQs

What is Lincoln Pharmaceuticals Ltd share price today?

Lincoln Pharmaceuticals Ltd share price today stands at ₹550.55, Open: ₹549, Previous Close: ₹548.25, High: ₹557.8, Low: ₹545, 52 Week High: ₹979.5, 52 Week Low: ₹499 as on .

How to buy Lincoln Pharmaceuticals Ltd shares ?

To buy Lincoln Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LINCOLN or Lincoln Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lincoln Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Lincoln Pharmaceuticals Ltd?

Today's traded volume of Lincoln Pharmaceuticals Ltd is 28.21K. Which means that 28.21K shares of Lincoln Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.

What is Lincoln Pharmaceuticals Ltd's market cap today?

Today's market capitalisation of Lincoln Pharmaceuticals Ltd is ₹1,098.13 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Lincoln Pharmaceuticals Ltd?

Lincoln Pharmaceuticals Ltd’s 52 week high is ₹979.5 and 52 week low is ₹499. The current share price of Lincoln Pharmaceuticals Ltd is ₹550.55, which is -43.79% down from its 52 week high and 10.33% up from its 52 week low.